West Pharmaceutical Services | WST - Sales Revenues

Stock Price
239.00
Daily Change
-0.42 -0.18%
Monthly
-1.98%
Yearly
3.74%
Q1 Forecast
228.35

West Pharmaceutical Services reported $805M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Align Technology USD 1.05B 54.3M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
Dentsply International USD 961M 57M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
ICU Medical USD 540.7M 3.7M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.6B 610M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Neogen USD 224.69M 15.5M Sep/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 724M 24M Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Rockwell Medical USD 25.83M 3.15M Jun/2024
Solventum Corp USD 1.99B 110M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Utah Medical Products USD 10M 400K Sep/2024
West Pharmaceutical Services USD 805M 400K Dec/2025